Phototriggered cytotoxic properties of tricarbonyl manganese(I) complexes bearing α-diimine ligands towards HepG2

Metal-based carbon monoxide releasing molecules with promising cytotoxic properties

Carbon monoxide, the "silent killer" gas, is increasingly recognised as an important signalling molecule in human physiology, which has beneficial biological properties. A particular way of achieving controlled CO administration is based on the use of biocompatible molecules that only release CO when triggered by internal or external factors. These approaches include the development of pharmacologically effective prodrugs known as CO releasing molecules (CORMs), which can supply biological systems with CO in well-regulated doses. An overview of transition metal-based CORMs with cytotoxic properties is here reported. The mechanisms at the basis of the biological activities of these molecules and their potential therapeutical applications with respect to their stability and CO releasing properties have been discussed. The activation of metal-based CORMs is determined by the type of metal and by the nature and features of the auxiliary ligands, which affect the metal core electronic density and therefore the prodrug resistance towards oxidation and CO release ability. A major role in regulating the cytotoxic properties of these CORMs is played by CO and/or CO-depleted species. However, several mysteries concerning the cytotoxicity of CORMs remain as intriguing questions for scientists.

In vitro cytotoxicity of Mn(I) and Ru(II) carbonyls with a diphenyl pyridyl phosphine coligand towards leukaemia

Human acute monocytic leukaemia cells were tested under both dark and light conditions for their susceptibility to Mn(I) and Ru(II) carbonyl complexes with a diphenyl pyridyl phosphine coligand. The Ru(II) complex (IC₅₀ = 7.13 ± 0.8 μM) displayed higher outstanding potency against leukaemia than the Mn(I) analogue (54.58 ± 4.1 μM) in the dark and both complexes were completely harmless to healthy mouse bone marrow cells.

Cytotoxicity of fac-Mn(CO)3 complexes with a bidentate quinoline ligand towards triple negative breast cancer

The cytotoxicity of two tricarbonyl Mn(I) complexes of the general formula fac-[MnBr(CO)₃L] (L = quinoline-2-carboxaldehyde (A) and 8-amino quinoline (B)) towards triple negative breast cancer (MDA-MB-231) was reported. Complexes A and B released CO when exposed to 468 nm light. Compound B has a dose-dependent cytotoxicity, with half maximal inhibitory concentration values of 19.62 μM and 11.43 μM before and after illumination, respectively. Co-treatment of MDA-MB-231 with paclitaxel (30 nM) and complex B (10 μM) resulted in a 50% reduction in cell viability.

Tricarbonyl triazolato Re(i) compounds of pyridylbenzimidazole ligands: spectroscopic and antimicrobial activity evaluation

Catalyst-free [3+2] cycloaddition coupling between [Re_n(N₃)_n(CO)_3nL] (n = 1, L = 1-ethyl-2-(pyridin-2-yl)benzimidazole (L¹) and n = 2, L = 1,1′-(hexane-1,6-diyl)bis[2-(pyridin-2-yl)-1H-benzimidazole] (L²)) and dimethyl acetylene dicarboxylate (DMAD) afforded mono- and binuclear triazolate complexes. Spectroscopic data presented unambiguous evidence for isomerization of the kinetically formed N(1) bound triazolate isomer into the N(2) analogue. The solvatochromism properties were assessed by UV/Vis spectroscopy with the aid of time dependent density functional theory calculations. The free ligands and their tricarbonyl triazolato Re(i) complexes were screened for their potential antimicrobial activity against different bacterial and fungal pathogens.

The antimicrobial activity and solvatochromism properties of mono- and binuclear tricarbonyl triazolato Re(i) complexes of pyridylbenzimidazole, formed by catalyst-free [3+2] cycloaddition reaction, were examined.